Gene expression analysis of aberrant signaling pathways in meningiomas

Oncology Letters

Volumn 6, Issue 1, 2013, Pages 275-279

  Torres Martín, Miguel ^a   Martinez Glez, Victor ^b   Peña Granero, Carolina ^a   Isla, Alberto ^b   Lassaletta, Luis ^b   De Campos, Jose M ^c   Pinto, Giovanny R ^d   Burbano, Rommel R ^e   Meléndez, Bárbara ^f   Castresana, Javier S ^g   Rey, Juan A ^a  

^a HOSPITAL UNIVERSITARIO LA PAZ IDIPAZ   (Spain)

^b HOSPITAL UNIVERSITARIO LA PAZ   (Spain)

^c Hospital UniversitarioFundación Jiménez Díaz   (Spain)

^d FEDERAL UNIVERSITY OF PIAUÍ   (Brazil)

^e FEDERAL UNIVERSITY OF PARÁ   (Brazil)

^f HOSPITAL VIRGEN DE LA SALUD   (Spain)

^g UNIVERSITY OF NAVARRA   (Spain)

Author keywords

Gene expression arrays; Meningioma; Neurofibromin gene; Schwannoma; Signaling pathways

Indexed keywords

CYCLIN DEPENDENT KINASE INHIBITOR 1A; EPIDERMAL GROWTH FACTOR RECEPTOR; FLICE INHIBITORY PROTEIN; GELATINASE B; HERMES ANTIGEN; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 8; METASTIN; NERVE CELL ADHESION MOLECULE; PROTEIN BAD; PROTEIN BAX; PROTEIN MDM2; TISSUE INHIBITOR OF METALLOPROTEINASE 1; VASCULOTROPIN A; VASCULOTROPIN RECEPTOR 1;

ANGIOGENESIS; APOPTOSIS; ARTICLE; CONTROLLED STUDY; DNA DAMAGE; DNA REPAIR; DOWN REGULATION; GENE EXPRESSION; HUMAN; MENINGIOMA; ONCOGENE; POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; UPREGULATION;

EID: 84878342675     PISSN: 17921074     EISSN: 17921082     Source Type: Journal    
DOI: 10.3892/ol.2013.1363     Document Type: Article

References (20)

1. Perry A, Louis DN, Scheithauer BW, et al: Meningiomas. In: Pathology and Genetics of Tumours of the Nervous System. World Health Organization Classification of Tumors. Kleihues P and Cavenee WK (eds). 2nd edition. IARC Press, Lyon, France, pp164-172, 2007.
2. Stemmer-Rachaminov AO, Wiestler OD and Louis DN: Neurofibromatosis type 2. In: Pathology and Genetics of Tumours of the Nervous System. World Health Organization Classification of Tumors. Kleihues P and Cavenee WK (eds). 2nd edition. IARC Press, Lyon, France, pp210-214, 2007.
3. Bello MJ, de Campos JM, Kusak ME, et al: Allelic loss at 1p is associated with tumor progression of meningiomas. Genes Chromosomes Cancer 9: 296-298, 1994.
4. Weber R, Boström J, Wolter M, et al: Analysis of genomic alterations in benign, atypical, and anaplastic meningiomas: toward a genetic model of meningioma progression. Proc Natl Acad Sci USA 94: 14719-14724, 1997.
5. Leone PE, Bello MJ, de Campos JM, et al: NF2 gene mutations and allelic status of 1p, 14q, and 22q in sporadic meningiomas. Oncogene 18: 2231-2239, 1999.
6. Mendiola M, Bello MJ, Alonso J, et al: Search for mutations of the hRAD54 geen in sporadic meningiomas with deletion at 1p32. Mol Carcinog 24: 300-304, 1999.
7. Lomas J, Bello MJ, Arjona D, et al: Analysis of p73 gene in meningiomas with deletion at 1p. Cancer Genet Cytogenet 129: 88-91, 2001.
8. Bello MJ, Amiñoso C, Lopez-Marin I, et al: DNA methylation of multiple promoter-associated CpG islands in meningiomas: relationship with the allelic status at 1p and 22q. Acta Neuropathol 108: 413-421, 2004.
9. Liu Y, Pang JC, Dong S, et al: Aberrant CpG island hypermethylation profile is associated with atypical and anaplastic meningiomas. Hum Pathol 36: 416-425, 2005.
10. Lomas J, Amiñoso C, Gonzalez-Gomez P, et al: Methylation status of TP73 in meningiomas. Cancer Genet Cytogenet 148: 148-151, 2004.
11. Lomas J, Bello MJ, Arjona D, et al: Genetic and epigenetic alteration of the NF2 gene in sporadic meninigomas. Genes Chromosomes Cancer 42: 314-319, 2005.
12. Pérez-Magán E, Rodríguez de Lope A, Ribalta T, et al: Differential expression profiling analyses identifies downregulation of 1p, 6q, and 14q genes and overexpression of 6p histone cluster 1 gene as markers of recurrence in meningiomas. Neuro Oncology 12: 1278-1290, 2010.
13. Tseng KY, Chung MH, Sytwu HK, et al: Osteopontin expression is a valuable marker for prediction of short-term recurrence in WHO grade I benign meningiomas. J Neurooncol 100: 217-223, 2010.
14. Aarhus M, Lund-Juhansen M, Knappskog PM: Gene expression profiling of meningiomas: current status after a decade of microarray-based transcriptomic studies. Acta Neurochir (Wien) 153: 447-456, 2011.
15. Pérez-Magán E, Campos-Martín Y, Mur P, et al: Genetic alterations associated with progression and recurrence in meningiomas. J Neuropathol Exp Neurol 71: 882-893, 2012.
16. Sayagués JM, Tabernero MD, Maillo A, et al: Microarray-based analysis of spinal versus intracranial meningiomas: different clinical, biological, and genetic characteristics associated with distinct patterns of gene expression. J Neuropathol Exp Neurol 65: 445-454, 2006.
17. Martinez-Glez V, Franco-Hernandez C, Alvarez L, et al: Meningiomas and schwannomas: Molecular subgroup classification found by expression arrays. Int J Oncol 34: 493-504, 2009.
18. Martínez-Glez V, Alvarez L, Franco-Hernández C, et al: Genomic deletions at 1p and 14q are associated with an abnormal cDNA microarray gene expression pattern in meningiomas but not in schwannomas. Cancer Genet Cytogenet 196: 1-6, 2010.
19. Ragel BT, Jensen RL: Aberrant signalling pathways in meningiomas. J Neurooncol 99: 315-324, 2010.
20. Torres-Martín M, Martinez-Glez V, Peña-Granero C, et al: Expression analysis of tumor-related genes involved in critical regulatory pathways in schwannomas. Clin Transl Oncol 15: 409-411, 2013.